This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Atrial Appendage Occluder Market

Explore FMI’s in-depth coverage on the Atrial Appendage Occluder Market to gain Exhaustive Analyses of Key Segments

Atrial Appendage Occluder Market by Type of Indication, Positioning of Device, End User& Region - Forecast 2022 – 2032

Atrial Appendage Occluder Market Snapshot (2022-2032)

[250 Pages Report] The global atrial appendage occluder market garnered a market value of US$ 854.6 Million in 2022 and is expected to register a staggering double-digit CAGR of 23.95% by accumulating a market value of US$ 7,316.9 Million in the forecast period 2022-2032.

Growth of the market can be attributed to the increasing geriatric population especially in North America and Europe. The market for atrial appendage occluder registered a CAGR of 8% in the historical period 2016-2021.

Data Points

Key Statistics

Expected Market Value (2022)

US$ 854.6 Million

Anticipated Forecast Value (2032)

US$ 7,316.9 Million

Projected Growth Rate (2022-2032)

23.95% CAGR

Atrial appendage, better described as left atrial appendage (LAA) is an ear-shaped pouch present in the top left chamber of the human heart (Left Atrium). The functional significance of this structure is unknown. In patients living with arrhythmic cardiovascular conditions such as atrial fibrillation, blood accumulates in the left atrial appendage and can cause clotting of blood.

The blood clots can cause fatal stroke when pumped into the blood vessels. Along with oral anticoagulants, occlusion of LAA by an occluder is an alternative approach to protect cardiovascular patients from strokes and other complications. Atrial appendage occluder is thus a kind of plug that permanently closes the appendage.

According to a study published in the journal, Clinical Medical Insights: Cardiology, atrial fibrillation affects around 2 percent of the global population and the prevalence of the disease is expected to increase five times over the next four decades, especially in the United States, owing to the expanding elderly population base.

Customize this Report

Let us know your requirement to get
100% FREE customization

Atrial Appendage Occluder Market Demand Analysis (2016 To 2021) Vs Market Outlook (2022 To 2032)

The global demand for atrial appendage occluders is projected to rise at a CAGR of 23.95% during the forecast period between 2022 and 2032, reaching a total of US$ 854.6 Million in 2032, according to a report from Future Market Insights (FMI). From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 8%.

The increasing number of cardiovascular patients suffering from atrial fibrillation and thromboembolism is the primary factor contributing to market growth. People's changing lifestyles, as well as the growing number of people suffering from obesity, diabetes, and hypertension, are increasing demand for the devices, contributing to market growth.

In the upcoming years, atrial appendage occluder market systems are expected to gain prominence as most new construction sites are already installing the same as a necessity. With the construction industry developing rapidly in emerging regions, the demand for Atrial appendage occluder market expected to rise.

Certain factors, such as the limited use of the LAA occluder for patients who have a high risk of bleeding as well as stroke while on anticoagulant therapy, are limiting the market's growth. Other factors limiting market growth include unfavourable policies and complications associated with surgery.

Which Are Some Prominent Drivers Of Atrial Appendage Occluder Market?

Growing Number of Cardiovascular Patients to Push Sales

The surging number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is a major driver to the growth of the global atrial appendage occluder market. Sedentary lifestyles and ailments like as diabetes, obesity, and hypertension will drive demand for such devices, paving the way for market expansion.

The global atrial appendage occluder market is extremely concentrated, with only a few players. Annually, roughly 15 million strokes occur worldwide, according to the World Health Organization (WHO). In 2010, the United States spent around US$ 53.9 billion on health care services, drugs, and lost work days due to a heart stroke.

Ischemic strokes account for approximately 87% of all strokes, which occur when blood circulation to the brain is compromised. Stroke is third among main causes of mortality, and it is also the leading cause of long-term disability. Around 20% of ischemic strokes are caused by atrial fibrillation. All of these factors are catalysing the growth of the atrial occluder market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Are The Challenges Faced By The Atrial Appendage Occluder Market?

Restricted Use of LAA Occluder to Stifle the Market Growth

The restricted use of LAA occluder solely for those at high risk of stroke and bleeding while on anticoagulant medication may limit market expansion.

Furthermore, difficulties associated with device implantation and removal, such as tissue erosion, which might necessitate open heart surgery, may function as a limiting factor for market expansion. Unfavourable policies concerning endocardial LAA closure are likely to hamper market expansion.

Region-Wise Insights

A Growing Geriatric Population Driving Demand for Atrial Appendage Occluders in North America?

As per FMI, North America is anticipated to dominate the atrial appendage occluders market during the forecast period. This is because of its vast geriatric population.

Furthermore, the region's huge population, which account for the highest number of stroke deaths, are the primary cause for individuals depending on atrial appendage occluders, particularly in the United States. Thus, in 2022, North America is anticipated to have a market share of 39.8% for atrial appendage occluder.

Is the Increased Risk of Atrial Fibrillation Fuelling the European Market for Atrial Appendage Occluders?

Europe’s Sedentary Lifestyles favouring Market Growth

According to a report published in the journal Indian Pacing and Electrophysiology Journal, the European Atrial appendage occluder market is likely to rise since more than 6 million Europeans are already living with arrhythmia, and the number is expected to double over the next 50 years.

According to one study, the European race has a greater incidence of atrial fibrillation than other races. Furthermore, due of sedentary lifestyles, the number of persons with cardiovascular problems is predicted to rise in developed nations, driving market development in the future.

This, in turn, is projected to serve the atrial appendage occluder market develops. As a result of the aforementioned factors, Europe is estimated to have a market share of 27.3% in the atrial occluder market in 2022.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-Wise Insights

Which Procedure of Positioning of the Device is the Most Lucrative in the Global Atrial appendage occluder Market?

Endocardial Segment to have the Highest Demand

The endocardial segment is anticipated to have the highest market share because they are both safe and effective. Several clinical studies on endocardial devices have yielded encouraging results for the patient population in terms of stroke risk reduction, contributing to the segment's market share.

Endocardial segment is likely to have a lower complication rate (around 8.5%) than Epicardial (25.4%), which is believed to drive segment growth. Epicardial has emerged as an alternative procedure for LAA closures with the goal of improving efficacy, especially in patients who have had poor results with the standard endocardial technique.

The Epicardial segment is forecasted to account for 15% of the global atrial appendage occluder market share during the forecast period.

Which End-Use Segment is Likely to Contribute Most to the Global Atrial appendage occluder Market?

Hospital Segment to be the Most Lucrative Segment

The hospital segment of the atrial appendage occluder market is expected to grow rapidly. The growing number of hospitals and the advancement of infrastructure are expected to drive demand for the devices. According to the Centres for Medicare and Medicaid Services, the United States spent approximately 3.6 trillion US$ on health-care management in 2018. This is expected to boost the market for atrial appendage occluder.

Furthermore, the rising prevalence of atrial fibrillation is expected to play a significant role in this segment. Atrial fibrillation is one of the most common heart conditions, according to the European Society of Cardiology.

The prevalence of atrial fibrillation in people aged 65 and older was around 7.6 million in 2016, and it is expected to rise by 89%, to around 14 million by 2060.Hence, the aforementioned factors are expected to increase hospital visits for atrial appendage management, increasing demand for atrial appendage occluder in this segment.

Start-Ups for Atrial appendage occluder Market

Key startup players in the atrial appendage occluder Market are:

Mitral Valve Repair at Vesalius Cardiovascular

In open-heart surgery, replacing the mitral valve carries a significant risk of infection and other complications. Medical professionals can correct mitral valve issues without major surgery using minimally invasive procedures such as Transcatheter Mitral Valve Replacement (TMVR).

Minimally invasive procedures are significantly less expensive than open-heart surgeries because the need for hospitalization before and after the procedure is greatly reduced. The pain is also significantly reduced, allowing the patient to recover more quickly. Startups and emerging companies create cardiovascular devices to assist doctors in replacing mitral valves in patients.

  • Vesalius Cardiovascular, a Canadian startup, has developed Calla, a transfemoral mitral valve repair system (TMVr). The biomedical device and delivery system developed by the startup enable percutaneous mitral valve repair. Its Orion TMVR (Transcatheter Mitral Valve Replacement) platform supplements the TMVr procedure and optimizes valve replacement. Furthermore, when repairing the mitral valve, Orion is able to eliminate common risks such as Left Ventricular Outflow Tract Obstruction (LVOTO).

MOST Cardio - Design Reusable Platform

Angioplasty is the traditional treatment for peripheral artery disease, which is caused by plaque buildup in the arteries. An atherectomy is a viable alternative to angioplasties for the treatment of atherosclerosis, a type of cholesterol and fat buildup in the arterial walls. This encourages startups to create minimally invasive endovascular solutions for clogged arteries.

MOST Cardio, based in the United States, creates cardiovascular surgical devices. The product portfolio of the startup includes proprietary guide wires with robotic guidance, proprietary catheters for plaque removal, and micro-emulsifiers for plaque emulsification.

The femoral artery is also used by the startup for minimally invasive surgeries, which reduces blood loss and potential infections. This solution also ensures that the arterial walls do not collapse or perforate while the procedure is being performed.

Market Competition

Key players in the atrial appendage occluder market include Appriva Medical Inc., Boston Scientific, Abbott, SentreHEART Inc, pfm medical ag., Occlutech, W. L. Gore & Associates, Coherex Medical, Inc., Cardia, Inc. and AtriCure, Inc. amongst others.

For developing commercial presence, these important actors focus strategic formulations such as research collaborations, new product releases, market penetration, and distribution alliances. Furthermore, these industry leaders are substantially spending in research activities, which encourage innovation and help them to commercialise improved products and maximise market income.

Recent Developments In The Atrial Appendage Occluder Market Are

  • In August 2022, Abbott and WW International, Inc. established a strategic alliance to assist people with diabetes better understand and manage their diabetes and weight. The companies are collaborating to integrate WeightWatchers' diabetes-specific weight management programme with Abbott's portfolio of FreeStyle Libre® products to create a seamless mobile experience that will provide people living with diabetes with the information and insights they need to make healthy dietary adjustments, improve their glucose levels, and, ultimately, gain more control of their health.
  • In July 2022, DURAMESH Suturable Mesh is being added to the product portfolio of PFM Medical AG. For the first time, this novel suturable mesh combines the benefits of mesh repair with the precise application of surgical sutures. When large pressures must be imparted, DURAMESH can be used in place of surgical sutures.
  • In June 2022, Boston Scientific Corporation, announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd to acquire its majority stake in M.I.Tech Co., Ltd, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I.Tech invented the HANAROSTENTTM technology, a line of conformable, non-vascular, self-expanding metal stents supplied in Japan by Boston Scientific since 2015. The acquisition price is KRW 14,500 per share, for a total of KRW 291.2 billion, or roughly $230 million at current exchange rates, subject to closing adjustments.
  • In June 2022, AtriCure, Inc., a pioneer in surgical treatments and therapies for atrial fibrillation, left atrial appendage (LAA) control, and post-operative pain management, announced that the first patient in the HEAL-ISTTM study has been treated (NCT 05280093). Drs. Mark LaMeir and Carlo de Asmundis treated the first patient at University Hospital Brussels. The HEAL-IST study will assess the safety and efficacy of AtriCure's Isolator® SynergyTM Clamp in the treatment of drug-resistant individuals with Inappropriate Sinus Tachycardia (IST).
  • In May 2022, B. Braun Interventional Systems Inc. has secured an exclusive distribution deal with Occlutech (BIS). With the backing of the worldwide Occlutech team, BIS will begin US commercialization initiatives for Occlutech's Flex II ASD Occluder. Through the agreement, Occlutech positions itself for success in the strategically crucial US market, which is regarded as a premier and commercially appealing healthcare system, while BIS expands the relevance of its portfolio around its strong congenital and structural heart emphasis.

Report Scope

Report Attribute

Details

Market Value in 2022

US$ 854.6 Million

Market value in 2032

US$ 7,316.9 Million

Growth Rate

CAGR of 23.95% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking,

Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Type of Indication
  • Positioning of Device
  • End USer
  • Region

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

  • Appriva Medical Inc.
  • Boston Scientific
  • Abbott
  • SentreHEART Inc
  • pfm medical ag.
  • Occlutech
  • W. L. Gore & Associates
  • Coherex Medical, Inc.
  • Cardia, Inc.
  • AtriCure, Inc.

Customization

Available Upon Request

Key Segments Profiled In The Atrial Appendage Occluder Industry Survey

Type of indication:

  • Non-valvular Atrial Fibrillation

Procedure of positioning of the device:

  • Endocardial
  • Epicardial

End user:

  • Hospitals
  • Clinics

Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Frequently Asked Questions

FMI projects the global atrial appendage occluder market to expand at a 21.3% value CAGR by 2032

The global atrial appendage occluder market is estimated at a market value of US$ 854.6 Million

The global atrial appendage occluder market is expected to garner a market value of US$ 7,316.9 Million

North America is expected to possess 39.8% market share for atrial appendage occluder market in 2022

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Procedure Of Positioning

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Procedure Of Positioning, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Procedure Of Positioning, 2022-2032

        5.3.1. Endocardial

        5.3.2. Epicardial

    5.4. Y-o-Y Growth Trend Analysis By Procedure Of Positioning, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Procedure Of Positioning, 2022-2032

6. Global Atrial Apendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        6.3.1. Hospitals

        6.3.2. Clinics

    6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Procedure Of Positioning

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Procedure Of Positioning

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Procedure Of Positioning

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Procedure Of Positioning

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Procedure Of Positioning

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Procedure Of Positioning

        10.3.3. By End User

    10.4. Key Takeaways

11. Asia Pacific Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Malaysia

            11.2.1.5. Singapore

            11.2.1.6. Australia

            11.2.1.7. Rest of Asia Pacific

        11.2.2. By Procedure Of Positioning

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Procedure Of Positioning

        11.3.3. By End User

    11.4. Key Takeaways

12. MEA Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Procedure Of Positioning

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Procedure Of Positioning

        12.3.3. By End User

    12.4. Key Takeaways

13. Key Countries Atrial Appendage Occluder Market Analysis

    13.1. U.K.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Procedure Of Positioning

            13.1.2.2. By End User

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Procedure Of Positioning

            13.2.2.2. By End User

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Procedure Of Positioning

            13.3.2.2. By End User

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Procedure Of Positioning

            13.4.2.2. By End User

    13.5. Rest of Latin America

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Procedure Of Positioning

            13.5.2.2. By End User

    13.6. Germany

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Procedure Of Positioning

            13.6.2.2. By End User

    13.7. U.K.

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Procedure Of Positioning

            13.7.2.2. By End User

    13.8. France

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Procedure Of Positioning

            13.8.2.2. By End User

    13.9. Spain

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Procedure Of Positioning

            13.9.2.2. By End User

    13.10. Italy

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Procedure Of Positioning

            13.10.2.2. By End User

    13.11. Rest of Europe

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Procedure Of Positioning

            13.11.2.2. By End User

    13.12. China

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Procedure Of Positioning

            13.12.2.2. By End User

    13.13. Japan

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Procedure Of Positioning

            13.13.2.2. By End User

    13.14. South Korea

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Procedure Of Positioning

            13.14.2.2. By End User

    13.15. Malaysia

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Procedure Of Positioning

            13.15.2.2. By End User

    13.16. Singapore

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Procedure Of Positioning

            13.16.2.2. By End User

    13.17. Australia

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Procedure Of Positioning

            13.17.2.2. By End User

    13.18. Rest of Asia Pacific

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2021

            13.18.2.1. By Procedure Of Positioning

            13.18.2.2. By End User

    13.19. GCC Countries

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2021

            13.19.2.1. By Procedure Of Positioning

            13.19.2.2. By End User

    13.20. South Africa

        13.20.1. Pricing Analysis

        13.20.2. Market Share Analysis, 2021

            13.20.2.1. By Procedure Of Positioning

            13.20.2.2. By End User

    13.21. Israel

        13.21.1. Pricing Analysis

        13.21.2. Market Share Analysis, 2021

            13.21.2.1. By Procedure Of Positioning

            13.21.2.2. By End User

    13.22. Rest of MEA

        13.22.1. Pricing Analysis

        13.22.2. Market Share Analysis, 2021

            13.22.2.1. By Procedure Of Positioning

            13.22.2.2. By End User

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Procedure Of Positioning

        14.3.3. By End User

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Appriva Medical Inc

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Boston Scientific

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Abbott

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. SentreHeart Inc

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. pfm medical ag.

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. Occlutech

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. W. L. Gore & Associates

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Coherex Medical, Inc.

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. Cardia, Inc.

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. AtriCure, Inc.

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Atrial Occluder  Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Atrial Occluder  Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032

Table 3: Global Atrial Occluder  Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 4: North America Atrial Occluder  Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 5: North America Atrial Occluder  Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032

Table 6: North America Atrial Occluder  Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 7: Latin America Atrial Occluder  Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Latin America Atrial Occluder  Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032

Table 9: Latin America Atrial Occluder  Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 10: Europe Atrial Occluder  Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Atrial Occluder  Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032

Table 12: Europe Atrial Occluder  Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: Asia Pacific Atrial Occluder  Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Atrial Occluder  Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032

Table 15: Asia Pacific Atrial Occluder  Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: MEA Atrial Occluder  Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: MEA Atrial Occluder  Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032

Table 18: MEA Atrial Occluder  Market Value (US$ Mn) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Atrial Occluder  Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032

Figure 2: Global Atrial Occluder  Market Value (US$ Mn) by End User, 2022-2032

Figure 3: Global Atrial Occluder  Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Atrial Occluder  Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 5: Global Atrial Occluder  Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Atrial Occluder  Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Atrial Occluder  Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032

Figure 8: Global Atrial Occluder  Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032

Figure 9: Global Atrial Occluder  Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032

Figure 10: Global Atrial Occluder  Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 11: Global Atrial Occluder  Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 12: Global Atrial Occluder  Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 13: Global Atrial Occluder  Market Attractiveness by Procedure Of Positioning, 2022-2032

Figure 14: Global Atrial Occluder  Market Attractiveness by End User, 2022-2032

Figure 15: Global Atrial Occluder  Market Attractiveness by Region, 2022-2032

Figure 16: North America Atrial Occluder  Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032

Figure 17: North America Atrial Occluder  Market Value (US$ Mn) by End User, 2022-2032

Figure 18: North America Atrial Occluder  Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Atrial Occluder  Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Atrial Occluder  Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Atrial Occluder  Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Atrial Occluder  Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032

Figure 23: North America Atrial Occluder  Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032

Figure 24: North America Atrial Occluder  Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032

Figure 25: North America Atrial Occluder  Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 26: North America Atrial Occluder  Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 27: North America Atrial Occluder  Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 28: North America Atrial Occluder  Market Attractiveness by Procedure Of Positioning, 2022-2032

Figure 29: North America Atrial Occluder  Market Attractiveness by End User, 2022-2032

Figure 30: North America Atrial Occluder  Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Atrial Occluder  Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032

Figure 32: Latin America Atrial Occluder  Market Value (US$ Mn) by End User, 2022-2032

Figure 33: Latin America Atrial Occluder  Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Atrial Occluder  Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Atrial Occluder  Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Atrial Occluder  Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Atrial Occluder  Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032

Figure 38: Latin America Atrial Occluder  Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032

Figure 39: Latin America Atrial Occluder  Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032

Figure 40: Latin America Atrial Occluder  Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 41: Latin America Atrial Occluder  Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: Latin America Atrial Occluder  Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: Latin America Atrial Occluder  Market Attractiveness by Procedure Of Positioning, 2022-2032

Figure 44: Latin America Atrial Occluder  Market Attractiveness by End User, 2022-2032

Figure 45: Latin America Atrial Occluder  Market Attractiveness by Country, 2022-2032

Figure 46: Europe Atrial Occluder  Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032

Figure 47: Europe Atrial Occluder  Market Value (US$ Mn) by End User, 2022-2032

Figure 48: Europe Atrial Occluder  Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Atrial Occluder  Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Atrial Occluder  Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Atrial Occluder  Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Atrial Occluder  Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032

Figure 53: Europe Atrial Occluder  Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032

Figure 54: Europe Atrial Occluder  Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032

Figure 55: Europe Atrial Occluder  Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 56: Europe Atrial Occluder  Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 57: Europe Atrial Occluder  Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 58: Europe Atrial Occluder  Market Attractiveness by Procedure Of Positioning, 2022-2032

Figure 59: Europe Atrial Occluder  Market Attractiveness by End User, 2022-2032

Figure 60: Europe Atrial Occluder  Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Atrial Occluder  Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032

Figure 62: Asia Pacific Atrial Occluder  Market Value (US$ Mn) by End User, 2022-2032

Figure 63: Asia Pacific Atrial Occluder  Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Atrial Occluder  Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Atrial Occluder  Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Atrial Occluder  Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Atrial Occluder  Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032

Figure 68: Asia Pacific Atrial Occluder  Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032

Figure 69: Asia Pacific Atrial Occluder  Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032

Figure 70: Asia Pacific Atrial Occluder  Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 71: Asia Pacific Atrial Occluder  Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 72: Asia Pacific Atrial Occluder  Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 73: Asia Pacific Atrial Occluder  Market Attractiveness by Procedure Of Positioning, 2022-2032

Figure 74: Asia Pacific Atrial Occluder  Market Attractiveness by End User, 2022-2032

Figure 75: Asia Pacific Atrial Occluder  Market Attractiveness by Country, 2022-2032

Figure 76: MEA Atrial Occluder  Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032

Figure 77: MEA Atrial Occluder  Market Value (US$ Mn) by End User, 2022-2032

Figure 78: MEA Atrial Occluder  Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Atrial Occluder  Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: MEA Atrial Occluder  Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Atrial Occluder  Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Atrial Occluder  Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032

Figure 83: MEA Atrial Occluder  Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032

Figure 84: MEA Atrial Occluder  Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032

Figure 85: MEA Atrial Occluder  Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 86: MEA Atrial Occluder  Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 87: MEA Atrial Occluder  Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 88: MEA Atrial Occluder  Market Attractiveness by Procedure Of Positioning, 2022-2032

Figure 89: MEA Atrial Occluder  Market Attractiveness by End User, 2022-2032

Figure 90: MEA Atrial Occluder  Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Interatrial Shunt Market

Published : September 2019

Healthcare

Appendage Management Market

Published : December 2021

Healthcare

Artery Compression Devices Market

Published : August 2018

Healthcare

Atrial Fibrillation Device Market

Published : November 2016

Google translate

Atrial Appendage Occluder Market